Skip to content Skip to footer

International Cannabis Weekly: 381

January 3, 2025

Highlights

Share this story
Highlights

FRANCE’S NEW HEALTH MINISTER EXTENDS MEDICAL CANNABIS PROGRAMME AGAIN, BUT PATIENTS URGED TO SEEK ALTERNATIVES

Thousands of French medical cannabis patients have been given a temporary reprieve, enabling them to continue accessing their treatment for another six months.

READ MORE  »

HOPE FOR HEMP: USDA NOMINATIONS AND NEW INITIATIVES DRIVE OPTIMISM

READ MORE »

DEA CRITICISED FOR FAILING TO RELEASE UPDATED ARREST AND SEIZURE DATA

READ MORE »

Highlights

Share this story
Europe

Highlights

Share this story
New Report

Highlights

Share this story
United States

Highlights

Share this story
Canada
  • High Tide celebrates key milestones in 2024, strengthening its position in the market.
  • Health Canada plans to publish cannabis sampling program results in upcoming months.
  • Stigma Grow reports record Q1 revenue of $9.6M, highlighting strong net earnings growth.
  • Tilray Brands reschedules earnings date to January 10 in observance of mourning day.

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact